EUR 26,15
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
EUR 26,43
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
EUR 26,75
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : New.
EUR 29,26
Quantité disponible : 6 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Langue: anglais
Edité par Vfmk Verlag für moderne Kunst GmbH, 2026
ISBN 10 : 399153214X ISBN 13 : 9783991532149
Vendeur : moluna, Greven, Allemagne
EUR 28,80
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Langue: anglais
Edité par Academic Press 2016-02-05, 2016
ISBN 10 : 0128022086 ISBN 13 : 9780128022085
Vendeur : Chiron Media, Wallingford, Royaume-Uni
EUR 120,53
Quantité disponible : Plus de 20 disponibles
Ajouter au panierHardcover. Etat : New.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 137,69
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 1st edition. 498 pages. 9.50x8.00x1.00 inches. In Stock.
Langue: anglais
Edité par Elsevier Science Publishing Co Inc, 2015
ISBN 10 : 0128022086 ISBN 13 : 9780128022085
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
EUR 149,43
Quantité disponible : Plus de 20 disponibles
Ajouter au panierHardback. Etat : New. New copy - Usually dispatched within 4 working days.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 110,38
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Elsevier Science Dez 2015, 2015
ISBN 10 : 0128022086 ISBN 13 : 9780128022085
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 150
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. 498 pp. Englisch.
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 158
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.